MYCN amplification in neuroblastoma can therefore induce a dose-dependent increase in the expression of genes with weak MYCN binding sites in their enhancers, thus promoting tumor-specific expression of MYCN target genes [45]. Here, MYCN is linked to neuroblastoma.